Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cortexyme, Inc. (CRTX)  
$0.71 0.01 (1.73%) as of 4:30 Fri 6/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 29,500,000
Market Cap: 20.95(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.6979 - $1.66
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Quince Therapeutics is a clinical stage biopharmaceutical company focused on therapeutic approaches to improve the lives of patients diagnosed with Alzheimer's and degenerative diseases. Co.'s portfolio of gingipain inhibitors are orally administered, brain-penetrating small molecules. Co.'s pipeline includes proprietary drug candidates for the treatment of CNS disorders including Alzheimer's disease, for the treatment of oncology applications including the prevention of oral squamous cell carcinoma, and for the treatment of conditions like periodontitis. Co.'s pipeline also includes proprietary irreversible protease inhibitors under development for the treatment of coronavirus infection.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 748,198 748,198
Total Buy Value $0 $0 $909,016 $909,016
Total People Bought 0 0 4 4
Total Buy Transactions 0 0 19 19
Total Shares Sold 0 0 0 1,871
Total Sell Value $0 $0 $0 $1,834
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-03-17 2023-12-15 2023-06-16 2022-06-16

   
Records found: 112
  Page 3 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lowe Christopher P. COO & Chief Financial Officer   •       –      –    2021-08-17 4 OE $2.23 $66,900 D/D 30,000 60,000     -
   Lowe Christopher P. COO & Chief Financial Officer   •       –      –    2021-08-16 4 AS $94.23 $2,096,779 D/D (22,000) 30,000 -87%     
   Lowe Christopher P. COO & Chief Financial Officer   •       –      –    2021-08-16 4 OE $2.23 $49,060 D/D 22,000 52,000     -
   Mcloughlin Margaret Director   –       •      –    2021-08-16 4 AS $94.55 $572,644 D/D (6,000) 0 -87%     
   Mcloughlin Margaret Director   –       •      –    2021-08-16 4 OE $17.00 $102,000 D/D 6,000 6,000     -
   Detke Michael J. Chief Medical Officer   •       –      –    2021-08-10 4 AS $100.00 $1,000,000 D/D (10,000) 0 -90%     
   Detke Michael J. Chief Medical Officer   •       –      –    2021-08-10 4 OE $2.23 $22,300 D/D 10,000 10,000     -
   Detke Michael J. Chief Medical Officer   •       –      –    2021-07-07 4 AS $53.24 $960,549 D/D (17,400) 0 -74%     
   Detke Michael J. Chief Medical Officer   •       –      –    2021-07-07 4 OE $2.23 $38,802 D/D 17,400 17,400     -
   Detke Michael J. Chief Medical Officer   •       –      –    2021-07-06 4 AS $53.43 $2,187,623 D/D (40,861) 0 -71%     
   Detke Michael J. Chief Medical Officer   •       –      –    2021-07-06 4 OE $2.23 $28,098 D/D 12,600 40,861     -
   Lowe Christopher P. COO & Chief Financial Officer   •       –      –    2021-06-30 4 OE $2.23 $66,900 D/D 30,000 30,000     -
   Lowe Christopher P. COO & Chief Financial Officer   •       –      –    2021-06-28 4 AS $53.39 $1,083,074 D/D (20,000) 0 -70%     
   Lowe Christopher P. COO & Chief Financial Officer   •       –      –    2021-06-28 4 OE $2.23 $44,600 D/D 20,000 20,000     -
   Mcloughlin Margaret Director   –       •      –    2021-06-28 4 AS $55.01 $30,333 D/D (550) 0 -70%     
   Lynch Casey Chief Executive Officer   •       •      –    2021-05-10 4 AS $33.75 $1,037,361 I/I (30,000) 978,774 162%     
   Lamond David Director   –       •      –    2021-03-24 4 B $33.77 $1,688,500 I/I 50,000 1,847,109 2.1 71%     
   Lynch Casey Chief Executive Officer   •       •      –    2021-03-22 4 AS $35.10 $1,067,611 I/I (30,000) 1,008,774 57%     
   Lamond David Director   –       •      –    2021-03-04 4 GA $0.00 $0 I/I 1,534,720 1,534,720     -
   Lamond David Director   –       •      –    2021-03-04 4 B $34.28 $1,767,057 I/I 50,000 1,797,109 2.1 51%     
   Lynch Casey Chief Executive Officer   •       •      –    2021-02-03 4 AS $37.39 $860,530 I/I (20,000) 1,038,774 7%     
   Lynch Casey Chief Executive Officer   •       •      –    2021-02-02 4 AS $36.02 $724,102 I/I (20,000) 1,058,774 32%     
   Lynch Casey Chief Executive Officer   •       •      –    2021-02-01 4 AS $34.60 $724,968 I/I (20,000) 1,078,774 33%     
   Holsinger Leslie Executive Vice President   •       –      –    2020-12-14 4 AS $28.80 $1,232,528 D/D (40,000) 3,500 29%     
   Holsinger Leslie Executive Vice President   •       –      –    2020-12-14 4 OE $0.27 $10,800 D/D 40,000 43,500     -
  112 Records found
  1  2  3  4  5   
  Page 3 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us